Finance

Lists
DTCFF:OTCMKTS
Defence Therapeutics Inc
$0.26
0.00%
(0.00) 1D
Nov 3, 3:14:45 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DTCFF...
Mkt. cap
25.43M
Avg. vol.
16.67K
Volume
0.00
52-wk high
$0.78
52-wk low
$0.19
Beta
2.37
Shares outstanding
76.11M
Mkt. cap
25.43M
Avg. vol.
16.67K
Volume
0.00
52-wk high
$0.78
52-wk low
$0.19
Beta
2.37
Shares outstanding
76.11M
News stories
From web sources and news partners
About Defence Therapeutics Inc
CEO-
Employees-
Founded2017
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Industry-
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
115.60K
316.51K
729.19K
280.05K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
353.71K
964.46K
401.52K
1.63M
Operating expense
599.46K
1.37M
1.16M
2.57M
Total operating expenses
599.46K
1.37M
1.16M
2.57M
Operating income
-599.46K
-1.37M
-1.16M
-2.57M
Other non operating income
-75.71K
-36.17K
-1.75M
1.15M
EBT including unusual items
-703.00K
-1.52M
-2.96M
-1.59M
EBT excluding unusual items
-703.00K
-1.52M
-2.96M
-1.59M
Income tax expense
-
-
-
-86.88K
Effective tax rate
-
-
-
5.48%
Other operating expenses
-
-
-
-
Net income
-703.00K
-1.52M
-2.96M
-1.50M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
631.00
-
2.27K
Interest expense
-11.92K
-111.06K
-76.49K
-142.67K
Net interest expenses
-11.92K
-110.43K
-76.49K
-140.40K
Depreciation and amortization charges
16.24K
9.28K
9.42K
37.17K
EBITDA
-589.88K
-1.36M
-1.15M
-2.52M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps